<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02173457</url>
  </required_header>
  <id_info>
    <org_study_id>CGZ302</org_study_id>
    <nct_id>NCT02173457</nct_id>
  </id_info>
  <brief_title>Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients</brief_title>
  <acronym>CMAS</acronym>
  <official_title>Phase III Study of Chiglitazar in Patients With Type 2 Diabetes Mellitus and Insufficient Glycemic Control Despite Diet and Exercise -- A Multicenter, Randomized, Double-Blind, and Sitagliptin-Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chipscreen Biosciences, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chipscreen Biosciences, Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with
      Sitagliptin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The efficacy and safety will be compared between Chiglitazar and Sitagliptin after treatment
      of 24 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HbA1c from baseline after 24 weeks of treatment</measure>
    <time_frame>24 weeks</time_frame>
    <description>The change of HbA1c at week 24 from baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in HbA1c from baseline for patients with a baseline HbA1c &gt;=8.5%</measure>
    <time_frame>24 weeks</time_frame>
    <description>The change of HbA1c at week 24 from baseline for patients with a HbA1c &gt;=8.5% at baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HbA1c from baseline for patients with a baseline HbA1c &lt;8.5%</measure>
    <time_frame>24 weeks</time_frame>
    <description>The change of HbA1c at week 24 from baseline for patients with a HbA1c &lt; 8.5% at baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in HbA1c from baseline</measure>
    <time_frame>12 weeks</time_frame>
    <description>The change of HbA1c at week 12 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients that attained target HbA1c &lt;7.0%</measure>
    <time_frame>24 weeks</time_frame>
    <description>Percentage of patients whose HbA1c at week 24 are &lt; 7.0%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients whose HbA1c lowered by at least 0.5%</measure>
    <time_frame>24 weeks</time_frame>
    <description>Percentage of patients whose change of HbA1c at week 24d from baseline are &gt;= 0.5%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting plasma glucose from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of fasting plasma glucose at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 2-h postprandial glucose (2hPPG) from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of 2-h postprandial glucose (2hPPG) at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in total cholesterol (TC) from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of total cholesterol (TC) at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in triglyceride from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of triglyceride at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in high density lipoprotein cholesterol (HDL-C) from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of high density lipoprotein cholesterol (HDL-C) at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in low density proprotein cholesterol (LDL-C) from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of low density lipoprotein cholesterol (LDL-C) at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in free fatty acid (FFA) from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of free fatty acid (FFA) at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in fasting plasma insulin from baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of fasting plasma insulin at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity assessed by the homeostatic model assessment (HOMA) at 12 and 24 weeks, compared with that of baseline</measure>
    <time_frame>12 and 24 weeks</time_frame>
    <description>The change of insulin sensitivity at week 12 and 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure from baseline</measure>
    <time_frame>24 weeks</time_frame>
    <description>The change of blood pressure at week 24 from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of patients who discontinue the trial due to hyperglycemia</measure>
    <time_frame>24 weeks</time_frame>
    <description>The percentage of patients who discontinue the trial due to hyperglycemia during the 24 weeks of treatment</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">738</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients administrate Chiglitazar 32mg once daily for 24 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients administrate Chiglitazar 48mg once daily for 24 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients administrate Sitagliptin 100mg once daily for 24 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chiglitazar</intervention_name>
    <description>Take orally</description>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_label>Arm 2</arm_group_label>
    <other_name>CS038</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sitagliptin</intervention_name>
    <description>Take orally</description>
    <arm_group_label>Arm 3</arm_group_label>
    <other_name>Sit</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Meet the WHO Diagnostic Criteria for Type 2 Diabetes (published on 1999);

          2. HbA1c≥ 7.5% and ≤ 10.0% after control of diet and exercises;

          3. Male and female,age between 18 and 70 years;

          4. BMI between 18.5-35kg/m2;

          5. Willing to be assigned to any treatment arm and sign inform consent.

        Exclusion Criteria:

          1. Type 1 diabetes;

          2. Treated by oral or injective antidiabetic drug before screening, including insulin and
             herb;

          3. Fasting plasma glucose &gt; 13.3 mmol/L (240 mg/dL);

          4. Resistant hypertension [blood pressure above the goal despite adherence to at least 3
             optimally dosed antihypertensive medications (including diuretic) of different
             classes,or blood pressure is controlled to below the goal by at least different
             classes of drugs];

          5. Plasma triglyceride &gt; 500 mg/dL (5.65 mmol/L);

          6. Is treating by fibrates;

          7. History of diabetic ketoacidosis,diabetic hyperglycemic hyperosmolar syndrome,lactic
             acidosis, diabetic hypoglycemia; or is currently combined with retinopathy, diabetic
             nephropathy and diabetic neuropathy;

          8. Had transient ischemic attack,cerebrovascular accident or unstable angina in the past
             6 months;

          9. History of myocardial infarction or had conducted coronary angioplasty or coronary
             artery bypass graft surgery;

         10. Had or is having pancreatic diseases;

         11. Heart failure (NYHA classification Stage III or IV), or left ventricular hypertrophy
             indicated by ECG;

         12. Hepatic diseases such as hepatocirrhosis, active hepatitis,aspartate aminotransferase
             or alanine aminotransferase &gt; 2.5 fold of the upper limit of the normal range;

         13. Kidney diseases or serum creatinine exceed the normal range: male &gt; 133 μmol/L or
             female &gt;108 μmol/L;

         14. Had malignancy in the past 5 years, not including basal cell carcinoma;

         15. Had or is currently receiving treatment that can alter blood glucose metabolism,
             including but not limited to diuretic,hormone (corticotropin or steroids),beta
             blockers;

         16. Have the diseases that can alter blood glucose metabolism, including but not limited
             to active hepatitis, hyperthyroidism,or adrenal tumors;

         17. Edema with unknown reason;

         18. Alcohol or drug addiction;

         19. Had participated other drugs' clinical trials in the 3 months before screening;

         20. Pregnant or lactic women; or women of childbearing age who are not able to or is not
             willing to conduct contraception;

         21. Any condition that make investigator consider the subject is not suitable to
             participate the trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weiping Jia, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai 6th People's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anhui Provincial Hospital</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital Affiliated to Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230022</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fuwai Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100037</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The General Hospital of the Chinese People's Armed Police Forces</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100039</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Artillery General Hospital of Chinese People's Liberation Army</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100068</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing Tongren Hospital Affiliated to Capital Medical Universtiy</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Third Hospital Affiliated to Guangzhou Medical College</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510360</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Shantou University Medical College</name>
      <address>
        <city>Shantou</city>
        <state>Guangdong</state>
        <zip>512021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shenzhen Second People's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beijing University Shenzhen Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <zip>518036</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zhongshan People's Hospital</name>
      <address>
        <city>Zhongshan</city>
        <state>Guangdong</state>
        <zip>528403</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangxi Medical University (The Eastern Hospital)</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangxi Medical University (The Western Hospital)</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Heibei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital Affiliated to Tongji Medical College of HUST</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital Affiliated to Nanhua University</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <zip>421001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Yueyang</name>
      <address>
        <city>Yueyang</city>
        <state>Hunan</state>
        <zip>414000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Inner Mongolia</name>
      <address>
        <city>Hohhot</city>
        <state>Inner Mongolia</state>
        <zip>010050</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huai'an First People's Hospital</name>
      <address>
        <city>Huai'an</city>
        <state>Jiangsu</state>
        <zip>223300</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gulou Hospital Affiliated to Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210008</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Second Hospital Affiliated to Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nanjing First Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Jiangsu University</name>
      <address>
        <city>Zhenjiang</city>
        <state>Jiangsu</state>
        <zip>212013</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>100031</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Siping Central People's Hospital</name>
      <address>
        <city>Siping</city>
        <state>Jilin</state>
        <zip>136000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Dalian Medical University</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <zip>116044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai Changzheng Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200003</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Qingpu Branch of Zhongshan Hospital Affiliate to Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200043</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tongji Hospital Affiliated to Tongji University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200065</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai First People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai 6th People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200235</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shanghai 5th People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200240</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Central Hospital of Minhang District of Shanghai</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201199</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xi'an Jiaotong University</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <zip>710061</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sichuan Provincial People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610072</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2014</study_first_submitted>
  <study_first_submitted_qc>June 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2014</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chiglitazar</keyword>
  <keyword>Sitagliptin</keyword>
  <keyword>diabetes</keyword>
  <keyword>type 2 diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sitagliptin Phosphate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

